Cargando…
Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management
Azithromycin has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to be used for Coronavirus disease 2019. Further, BCG vaccination is being considered for clinical tri...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192107/ https://www.ncbi.nlm.nih.gov/pubmed/32360581 http://dx.doi.org/10.1016/j.phrs.2020.104874 |